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ABSTRACT OF THE THESIS

Computational Imaging Methods for Analysis of DaTScan SPECT Images
by
Hae Sol Moon
Master of Science in Biomedical Engineering
Washington University in St. Louis, May 2020
Research Advisor: Professor Abhinav K. Jha

There is an important need to develop biomarkers to improve the diagnosis and assess the
severity of Parkinson’s disease (PD). The potential to derive such biomarkers from quantitative dopamine transporter scan (DaT-Scan) single-photon emission computed tomography
(SPECT) imaging, in particular the uptake of DaT in the caudate, putamen, and globus
pallidus regions, is highly appealing as imaging is non-invasive and DaTScan is already used
in the management of patients with PD. However, reliable quantification requires reliable
segmentation of these regions in these images. Reliable segmentation is challenging due to
the limited spatial resolution and high image noise in SPECT images and the physiological
variability in these regions. To address this issue, we propose a three-dimensional physicsguided estimation-based method for segmenting SPECT images. The method implicitly
incorporates the prior distribution of boundaries of caudate, putamen and globus pallidus,
as can be obtained from high-resolution MR images of patients scanned previously, during
the training process. Our approach is guided by the physics of the SPECT imaging, and
thus inherently accounts for the two sources of partial volume effects in SPECT images,
ix

namely limited system resolution and tissue-fraction effects. The proposed method was evaluated both qualitatively and quantitatively using highly realistic simulation studies. The
method yielded accurate boundaries of the caudate, putamen, and globus pallidus regions,
provided reliable estimates of the specific binding ratios of these regions, and significantly
out-performed several commonly used segmentation methods. We have implemented geometric transfer matrix (GTM) method that uses this delineated boundary to compensate for
partial volume effects, with the goal of estimating more accurate quantification results.
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Chapter 1
Introduction

1.1

Non-invasive Brain Imaging

The field of brain imaging stems from an effort to be able to detect and measure physical
phenomena of the neural activity and biochemical reactions and properties of the brain. The
brain is a especially difficult organ to image for numerous reasons. First, because there are
numerous biochemical phenomena inside the brain with various yet unexplored pathways
and corresponding structures and proteins, it is difficult to pin-point a specific phenomena
of interest. Also, the neural connection between neurons and their cooperation are still
not fundamentally understood. The presence of thick human skull makes it difficult for an
imaging source such as light and sound to penetrate and lose information. Thus, an imaging
device that works in small animals may not perform reliably on the human brain due to
thicker and denser skull than that of small animals which creates intense attenuation for
sound, light and radiation-based imaging.
Many efforts have been made to come up with imaging devices to tackle these problems
and to study the brain. One of the first imaging modalities is EEG, which uses electrodes
that are placed on the head of subjects to measure electrical response of neural activities.
By using multiple channels, EEG provides a general understanding of spatial and temporal
neuronal activity from corresponding electrical responses of the neurons. Thus, one can
measure the neural activity with EEG devices and approximate the region responsible of the
brain activities.

1

Many other efforts in imaging the brain have been conducted with the development of magnetic resonance imaging (MRI), computed tomography (CT), single photon emission computed tomography (SPECT), and positron emission tomography (PET). MRI machines use
magnetic fields to measure different anatomical densities within the brain to acquire images of the brain structure. Magnetic fields are applied to the subject via coils and excite
the electrons. Depending on the time constant for relaxation of tissue molecules to reach
the equilibrium, MRI machines can detect such differences and allows visualization different structures within the brain. With the improvement and development of various MRI
techniques such as neuromelanin sensitive MRI, fMRI and diffusion tensor MRI, researchers
are able to use MRI for more specific study of interest such as imaging the structure of
substantia nigra which has been a challenge with conventional T1 and T2 scans, monitor the
neuronal activity level of brain regions by detecting blood flow into regions, and understand
the connectivity of brain structures [82, 60, 1].

1.2

Nuclear-Medicine Imaging

Nuclear-medical imaging devices such as PET and SPECT are based on radioactive materials
called radionuclides or x-rays to penetrate the bone and tissues to aid understanding of the
biochemical properties at receptor sites, metabolism and functionality of specific tissue or
area of body. The main imaging modalities of the brain in nuclear-medicine imaging include,
SPECT and PET. For brain studies, nuclear-medicine imaging devices have widely been used
due to their ability to penetrate the thick human skull which has been a challenge for many
optical and sound based medical devices such as the OCT and ultrasound. In oncology, with
the usage of radioactivity-labelled molecules that bind to area of metabolic activity, clinicians
are able to acquire numerous information regarding the location, size and heterogeneity of
the tumor. Also, nuclear-medical imaging modalities can achieve diagnostic information
even at the receptor sites which made them especially useful for DA and DAT scanning for
dopaminergic neurodegenerative conditions such as Parkinson’s disease (PD) and dementia
with Lewy bodies [98, 45].
In SPECT scanning, Anger camera rotates 360 degrees around the source of interest to acquire a 3D imaging of emitted gamma rays for about 120 angle points. Whereas in PET, the
2

detectors are aligned to form a circular ring around the source without rotation. PET uses
positron emission which after annihilating with an electron, yields two photons in diametrically opposite directions, so that two gamma rays are detected in the detector ring from a
single event. Based on the location of the detectors that are hit by the two gamma rays and
with the calculation of the time difference between the two gamma rays, an approximate
location of the source of gamma rays can be determined.
CT scans are widely used together with nuclear-medicine modalities such as SPECT and
PET. The physics of CT scans are based on X-rays scans for 360 degrees around a subject
to get numerous projection maps of the source similar to those of a SPECT system. The
projection images are reconstructed for 3D image of the source by clinicians. The image
acquired shows different structure of the brain depending on their ability to absorb the Xray particles. In brain imaging, such images are used by clinicians to see the signs of head
injuries and brain tumors. Also, the ability of CT scans to clearly differentiate the skull from
other brain tissues allows combination of CT with SPECT or PET scans because in SPECT
and PET, the information of the location of skull is important for attenuation correction due
to information loss by high attenuation coefficient and the thickness of human skull [92].

Figure 1.1: Clinical brain SPECT scanning

3

1.2.1

Single Photon Emission Computed Tomography

Single Photon Emission Computed Tomography (SPECT) is tomographic imaging system
in nuclear-medicine widely used for diverse clinical and research purposes including in oncology, cardiology, and neuroimaging. A SPECT system detects gamma rays from photon
emission of radionuclide tagged tracer distributed throughout the body that is injected into
the subject. The specific tracer binds to or becomes trapped by physiological properties and
during the radioactive decay of radionuclide of the tracer, gamma rays are emitted. The
gamma rays travel and reach the detectors of SPECT.
A SPECT systems has a unique part called collimators. The collimators are stationed in front
of the detectors to allow only gamma rays that are directly parallel to the detector and reach
the scintillation crystals. The scintillation crystals as a main part of the detector, transmit
light when hit by gamma ray particles and the intensity of produced light gets multiplied
in the photo-multiplier tube stationed after the scintillation crystals and following photosensors convert the light into electrical signal to map the projection data [13]. The detection
of gamma rays, which are converted into the electrical signals, allows the mapping and thus,
the understanding of biochemical properties and reactions of interest. A simple schematic of
SPECT imaging starts with the injection of radio-pharmaceutical into the body of subject,
uptake of such radio-pharmaceutical into the regions of interest, data acquisition of SPECT
imaging, and image reconstruction/analysis.

SPECT Simulations
In order to conduct studies in economically and timely efficient manner, in numerous SPECT
research studies, prior to testing on a clinical SPECT scanner, computerized simulations of
SPECT imaging are used. This allows more freedom in experimenting with numerous parameters and techniques to acquire ideal SPECT setting on computers. Simulations also allow
modeling population variability. However, in order to achieve a highly realistic simulations,
SPECT physics processes have to be incorporated mathematically such as collimator-detector
response, attenuation and scatter in both simulations and reconstruction protocols [59]. Especially, the collimator and detector determine resolution of the system. The collimator also

4

Figure 1.2: Physics of pinhole SPECT adopted from Aoi et al.[2]
determines the sensitivity of a SPECT scanner. The factors that affect collimator resolution include distance from the source to collimator, hole size, and hole shape. Typically,
low energy and high resolution collimators (LEHR) are used for DatScan studies and has
around 7.4 mm FWHM at 10 cm [86]. Further, scintillating crystals and photo-multiplier
tube determine the intrinsic resolution. Intrinsic resolution varies between SPECT scanners
but generally is around 4 mm FWHM [86].
The mathematical modeling of the deterministic portion of any imaging system can be
expressed through the formalism g=Hf, where f is the object that is being imaged, and g
is the acquired data from the imaging system. H represents the system response and the
behavior of the imaging system and in a linear discrete-to-discrete system, can be expressed
in a matrix form, also referred to as the system matrix. In order for a simulation method
5

to be realistic, it is important to take into accounts of various SPECT imaging physics and
to achieve a reliable digital phantom of the uptake distribution depending on the type of
isotope used in the study.

SPECT Reconstruction
After acquiring the H matrix, an iterative reconstruction method namely maximum likelihoodexpectation maximum (ML-EM) and ordered subset-expectation maximum methods are used
for reconstruction (OS-EM) [51, 28]. The method computes the ratio between measured and
estimated projection and the back projection of the ratio will be multiplied to previous iteration of estimated image to generate image of new iteration. The difference between measured
and estimated projection will be incorporated into each iteration and after a specific iteration, theoretical and measured image will become similar. Thus, it is highly important to
achieve a highly realistic H matrix that incorporates the realistic nature of a SPECT system
configuration into account.
In each iteration of ML-EM, an updated reconstructed image can be explained and mathematically expressed as follows:
Image(k+1) = Image(k) × N ormalized Backprojection of [

measured projection
] (1.1)
estimated projection(k)

M
(k)
X
gm
f¯n
(k+1)
¯
Hmn
fn
= PM
PN
¯(k)
0f
H
0
0
mn
m0 =1 Hm0 n m=1
n
n =1

1.3

(1.2)

Parkinson’s Disease

Neurodegenerative disorders are characterized by irreversible degeneration of neuronal cells
that deteriorates various functionalities of the brain including cognitive abilities. Parkinson’s
disease is the second most common neurodegenerative disease after Alzheimer’s [19, 63]. The
diagnostic symptoms of PD are rigidity, bradykinesia, akinesia, abnormal posture and resting
tremor [62]. Bradykinesia is the slowing of muscle movement and akinesia represents the loss
6

of voluntary muscle movement. Ridgitity refers to stiffness of the muscle. These symptoms
occur due to the inability of the PD patients to relax undesired muscle contraction. Also,
tremor is one of the most commonly associated with patients with PD. A tremor refers to a
rhythmic, oscillating and involuntary movement or shake that occurs in the body [85]. This
behavior also occurs in other motor-related illnesses such as essential tremor, a neurological
disease that causes involuntary tremor when trying to move muscle. However, in PD, tremor
occurs in a resting state, which is known as resting tremor that occurs even when the patients
are at rest. The resting tremor not only occurs in fingers and large muscles such as foot,
hand, leg or arm but also lips, jaw and tongue [30]. The symptoms that are related to motor
functions such as muscle control, balance and movement can be explained by the neuronal
loss in the substantia nigra where most of the dopamine neurons are located, as will be
explained more in detail.
Further, non-motor symptoms such as depression, apathy, sleep disorders and erectile dysfunction are known to occur in patients with PD [6]. It is still unclear the exact pathway
and the cause of such neurodegeneration in PD. In most cases, the diagnosis of PD occurs
after about 50% of dopamine neurons have already been lost [12]. Also, PD is sometimes
misdiagnosed and an accurate diagnosis is challenging [12].

1.3.1

Basal Ganglia

Direct Pathway
Basal Ganglia is a group of structures that includes caudate, putamen, globus pallidus and
midbrain that takes a crucial role in the neuronal circuit of the brain. The basal ganglia is
connected to the motor cortex and the thalamus through inhibitory and excitatory synapses
with GABA and glutamate as neurotransmitters. In a voluntary movement, when a person
tries to move, the motor cortex sends an excitatory signal with the release of glutamates
into the striatum which then inhibits globus pallidus internal (GPi) as the striatum releases
GABA. When GPi is inhibited, the normal inhibitory effect on the the thalamus is also
inhibited which in turn, excites the thalamus. Then, the excited thalamus sends excitatory
signal to the motor cortex and excites the muscles for movement.
7

Figure 1.3: Basal ganglia
The substantia nigra has a regulatory role in the direct pathway. The striatum contains D1
dopamine receptors that receive dopamine from substantia nigra. The substantia nigra connects with the inhibitory neurons from striatum and globus pallidus through dopaminergic
neurons in the niagrostriatal pathway. When striatum receives dopamine from substantia
nigra, GPi is more inhibited leading to amplified effect in the direct pathway. Such response
is regulated with the amount of dopamine transported from the substantia nigra to the
striatum.

Indirect Pathway
The indirect pathway of muscle movement mainly occurs to prevent undesirable movement
by inhibiting the execution of thalamus which excites the motor cortex. GPi controls the
thalamus by inhibiting thalamus. Also, the motor cortex excites the striatum and inhibits
8

globus pallidus external (GPe), which then inhibits the connection with subthalamic nucleus.
This results in excited subthalamic nucleus that sends excitatory messages to GPi which
inhibits the activity of thalamus by sending out more GABA neurotransmitters. Then,
thalamus sends less excitatory signal to the motor cortex and leads to a decreased muscle
movement. The substantia nigra also plays an important role in the indirect pathway as a
regulator. The substantia nigra sends dopamine which binds to D2 receptors in the striatum.
With the increase of dopamine binding to D2 receptors results in less inhibitory response to
GPe from the striatum in the indirect pathway. The level of dopamine controls the response
of thalamus leading to either increased or decreased muscle movement.

Figure 1.4: Basal Ganglia Pathway adopted from Olanow et al., modified by Delong and
Young et al.[70]

What Happens in Parkinson’s Disease?
In PD, dopaminergic neurons in the nigrostriatal pathway which connects the substantia
nigra and striatum dies due to unknown causes. Similar to Lewy body dementia, in PD,
9

there exists an accumulation of abnormal protein bundles called Lewy bodies which form
in the substantia nigra [88]. As the dopaminergic neurons die, less dopamine is transported
from the substantia nigra to the striatum that effects both direct and indirect pathway of
muscle movement. In the direct pathway, the goal is to excite thalamus to induce muscle
movement. However, in PD, due to loss of dopaminergic neurons leading to decreased levels
in the striatum, the thalamus is less activated which leads to reduced muscle movement.
In the indirect pathway, as dopamine levels decrease in the striatum, the ”fine-tuning”
ability of substantia nigra as a regulator of muscle movement is reduced. Thus, the loss of
dopaminergic neurons leads to less dopamine movement from substantia nigra to striatum
and causes loss of the ability to trigger extensive muscle movement and to prevent excessive
movement evident from slow movement and resting tremors of patient’s with PD.
Also, there is an increasing need for clinical investigation of globus pallidus in PD [52, 53, 9,
8, 79]. There has been an observed correlation between DaT reduction in globus pallidus and
resting tremor severity which is one of the distinct symptoms of PD [26]. Studies have found
an increase in F-dopa uptake in GPi in early stages of PD [100]. The authors hypothesized
that the uptake in GPi was increased to maintain a more normal pattern of pallidal output to
ventral thalamus and motor cortex to compensate for the early degeneration of nigrostriatal
dopaminergic neurons. As the disease progressed, uptakes in GPi then gradually decreased.
The authors suggested that the loss of this pathway in PD may be an important step in the
progression of the disease. These findings bring significant interest in quantifying uptake in
globus pallidus.

1.3.2

Diagnostic Techniques

UK PD Society Brain Bank Criteria
The UK PD society brain bank criteria is a widely used clinical diagnostic criteria for PD
developed by PD society brain bank (PDSBB) in London [29]. The criteria begins with
the diagnosis of Parkinsonian Syndrome with bradykinesia, and presence of at least one
of muscular rigidity, 4-6 Hz of rest tremor and postural instability not caused by primary
visual, vestibular, cerebellar or proprioceptive dysfunction [29]. Next step is to perform
exclusion criteria for PD which includes history of repeated strokes, head injury, more than
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one affected relative, presence of cerebral tumor, exposure from MPTP and more [29]. The
final step is the supportive prospective positive criteria for PD. Three or more of the last
criteria step are required for a diagnosis of definite PD as well as the check for the first step
which includes, unilateral onset, presence of rest tremor, disorder progression, asymmetry of
affected side, 70-100 % response to L-Dopa, severe L-Dopa induced chorea and a response
from longitudinal study [29].

United PD Rating Scale
The united PD rating scale (UPDRS) is a scaling system that rates the severity of PD based
on symptoms which ranges from 0 to 199 maximum points. The UPDRS has four parts
including non-motor experiences of daily living, motor experiences of daily living, motor
examination and motor complications [23]. The first part includes psychological symptoms
such as cognitive impairment and hallucination and in part two, motor symptoms including
handwriting and tremors and speech are examined [23]. The first two parts are performed
through an interview with a physician, part three is a structured physical examination for
motor performance and the last section is performed through interview and observation [23].

1.4
1.4.1

Dopamine Transporter SPECT scans
Ioflupane

The loss of dopaminergic neurons is one of the main symptoms of PD. Thus, it is compelling
to investigate metrics that can show the changes of dopaminergic neurons as biomarkers.
Ioflupane (I-123) is a radionuclide that is a cocaine analogue. Cocaine analogues have a
high affinity to dopamine transporters in the presynaptic terminal of dopaminergic neurons
especially found in the striatum [5, 83]. The affinity of I-123 to dopamine receptors depends
on the availability of DaT in the presynaptic terminal which is affected by the severity of
PD. Thus, patients with severe PD will have reduced DaT uptake in the striatum region
and that will be largely asymmetric. Radiologists visually assess SPECT scans as one of the
criteria of the differential diagnosis.
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1.4.2

Image-Analysis-Related Challenges

Various segmentation methods in medical imaging have been developed for numerous purposes. Such methods serve the goal of extracting region of interest such as tumors or lesions.
Also, in MRI images, segmentation methods have been developed to delineate various structures of the brain. This is made possible by relatively higher resolution and lower noise levels
of MRI images of the brain. A program called Freesurfer is used in this study to segment
T1 MRI images into various regions of the brain such as caudate, putamen, globus pallidus,
grey matter and white matter [20]. However, in nuclear-medicine imaging and especially in
SPECT scans, images are largely distorted due to partial volume effects resulted from high
noise and low resolution of imaging systems. Thus, conventional intensity-based segmentation methods of SPECT images such as thresholding, gradient-based and MRF-GMM suffer
from low segmentation accuracy because the shape difference between an actual structure of
region of interest and visual shape in SPECT images are quite different. There have been
numerous studies to determine a quantitative biomarker for PD through DaTscan SPECT
but a reliable early detection method and a biomarker that correlates with the progression
and severity of PD have yet to be developed. In many studies, simpler and less accurate
segmentation methods such as thresholding were used and more focus was on the analysis aspect instead of the segmentation accuracy. Thus, there is a need for a segmentation method
that accounts for PVEs and a quantification method that also accounts for PVEs. This
study focuses on both aspects of these problems to achieve the goal of accurate quantification that largely corrects PVEs. In our study, we focus on achieving accurate segmentations
and use those segmentations to develop a quantitative biomarker for assessing mean uptake
in regions of interest.

1.4.3

Proposal

We propose to address the challenges with analysis of DaTscan SPECT images through
the development of new image analysis methods. In this thesis, we focus on developing
and evaluating these tools in the context of analyzing the caudate, putamen, and globus
pallidus regions thus, developing a robust quantification metric for in vivo phenomena. We
are interested in quantifying the uptake in globus pallidus along with widely studied caudate
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and putamen to investigate the correlation between uptake in globus pallidus and the severity
of PD as well as to advance understanding of pathological role of globus pallidus in PD
[26, 52, 53, 9, 8, 79, 100]. In clinical trials [101, 78, 22, 16, 50], including the seminal
ELLDOPA study [24] and MPTP-treated non-human primate studies [96, 42, 94], striatal
measures did not fully correlate with the severity of PD, thus limiting the effectiveness of
only using striatal uptake as a biomarker to measure or predict the progression of PD.
Thus, a combined analysis of caudate, putamen and globus pallidus, may provide useful
information that hasn’t been explored yet. We first propose a new estimation-based approach
to SPECT segmentation that integrates the physics of SPECT imaging with a learningbased approach. We observe that the proposed method yields accurate segmentations of the
caudate, putamen, and globus pallidus in brain SPECT images, as evaluated using realistic
simulation studies. The method is described in Chapter 2. In Chapter 3, a PVC method
is developed to address the issues of PVEs in quantification. This approach builds upon an
approach initially proposed in Du et al. and demonstrates promise in the task of PVC from
SPECT images. In summary, this thesis seeks to develop tools to address the challenges of
segmentation and PVC in DaTscan SPECT images, specifically in the context of performing
reliable quantification from the caudate, putamen, and globus pallidus regions of the brain.

13

Chapter 2
A physics-guided learning-based
estimation method for fully
automated 3D DaT-Scan SPECT
segmentation1

2.1

Introduction

Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s
disease and is estimated to affect 12 million people worldwide by 2040 [19, 63]. Dopamine
transporter (DaT) SPECT scans are conducted to improve diagnosis, and more specifically,
to separate PD from other Parkinsonian syndromes such as Essential Tremor [83]. For this
purpose, conventionally, DaTscan images are analyzed visually. However, several studies
are investigating whether quantitative uptakes in the striatal regions, i.e. the caudate and
the putamen, can help with more accurate diagnosis [40]. Also, there is significant interest in using quantitative DaT SPECT-derived measures for measuring disease severity in
patients with PD [53, 52, 77]. Moreover, studies have shown evidence of DaT in globus
pallidus (GP) [8, 75] and its correlation to motor severity and progress of PD [53]. For all
these studies, there is a need for methods to quantify regional DaT uptakes from SPECT
1

This chapter forms the basis of an article that will be submitted to a journal. Authors include Hae
Sol Moon, Ziping Liu, Richard Laforest, Maria Ponisio and Abhinav K. Jha. Abstracts based on this work
have been accepted to the IEEE International Symposium on Biomedical Imaging 2020 and the Society of
Nuclear Medicine and Molecular Imaging Annual Meeting 2020
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images. Additionally, there is substantial interest in using shape analysis of the caudate
and putamen boundaries to develop biomarkers for PD [89, 76]. Further, texture analysis
of DaTscan images is also being explored [65, 3]. Conducting these quantification, shape
and texture-analysis studies requires reliable segmentation of the caudate, putamen, and GP
regions from DaT-scan SPECT images.
Segmentation in SPECT is challenging in general due to the low resolution and resultant
partial-volume effects (PVEs, high noise and physiological variability between subjects [4,
14]. The problem is further compounded in DaTscan SPECT because of the small sizes of
the caudate, putamen, and GP regions. In fact, the GP is visually almost impossible to
demarcate from SPECT images. The commonly used segmentation procedure for SPECT is
manual delineation by trained readers. However, manual delineation is expensive, tedious,
time consuming, and suffers from intra-and inter-reader variability, especially due to the poor
resolution and high noise in SPECT [33]. To address this issue, several semi-automated
SPECT segmentation methods have been proposed, such as those based on thresholding
[61, 97], edge-detection [61], region-growing [84], and clustering [68]. However, our studies
show that these methods yield limited performance when applied to DaT-scan SPECT. This
was primarily due to the lack of clear boundaries and the relatively low tracer uptake in the
GP region. Often times these existing methods segmented the caudate, putamen and GP
as just one unified region, which limits the ability to quantify regional uptakes from these
regions. A recent study showed that metrics measured from DaTscan SPECT after applying
a semi-automated segmentation method yielded large variabilities, and thus were clinically
not useful [66]. Thus, there remains an important need for improved methods to segment
DaTScan brain SPECT images.
To address this need, we recognize that a major barrier to segment DaTscan SPECT images
into caudate, putamen, and GP is the lack of clear boundaries between these regions in these
images. This arises due to the PVEs in reconstructed SPECT scans. These PVEs have two
sources: limited system resolution and tissue-fraction effects (TFEs). Clinical brain SPECT
systems typically have resolution of the order of ∼ 8 mm, and following reconstruction, the
resolution in the reconstructed image can be around ∼ 12 mm. [90, 10] Thus, structures such
as caudate, putamen and GP, which are close to each other, are significantly affected by the
system-generated blur. Further, due to reconstruction of the image over a finite-sized voxel
grid, it is likely that a voxel contains more than one region. While this is generally an issue
15

in medical imaging, the effect is more prominent in SPECT due to the larger reconstructed
voxel sizes.
Conventional segmentation methods are designed as classifiers, in that they classify a voxel
as belonging to a certain region. Thus, they are inherently unable to account for the TFEs.
To address this issue in the context of segmenting oncological 2-D PET images, Liu et al.
[58, 57] have proposed an estimation-based segmentation method. The method instead of
classifying a pixel as tumor or background, estimates the fractional area that the tumor
occupies within each pixel. We now propose to extend this technique in the context of
segmenting multiple regions, namely the left and right caudate, putamen and GP, from 3-D
SPECT images. The estimation-based segmentation technique is a Bayesian approach, and
as shown later, requires a distribution of the fractional volumes that the caudate, putamen,
and GP regions occupy in each voxel. To obtain this distribution, we use the fact that these
regions are separately visible on T1-weighted MR images, where they can be easily delineated.
Since the T1-weighted MR images are anatomical, this provides the anatomical fractional
volumes in each voxel for the different regions. The proposed method uses this distribution
to estimate the posterior mean of the fractional volumes of the caudate, putamen, and GP
regions from the DaT-scan SPECT images. These estimates yield the segmentations of these
regions over a continuous non-voxelized grid, analogous to segmentation of a high-resolution
image.
This paper is organized in the following sections. In Section 2.2, we provide the theoretical
formalism, implementation, and evaluation of the proposed method. An important component of the evaluation study is investigating the performance of the method when there is a
mismatch between the distribution learned from the MR image population and the SPECT
image. We investigate the sensitivity of the method to these mismatches. The results are
presented in Sec. 2.3. Finally, the implications of the results along with limitations and
future directions are presented in Sec. 2.4, followed by the conclusions in Sec. 2.5.

16

2.2
2.2.1

Methods
Theory

Problem formulation
Let f (r) describe the DaT tracer distribution within the brain for a patient injected with
this tracer, where r is a 3D vector denoting spatial location. Consider a SPECT system that
images this 3D tracer distribution and yields sinogram data. The sinogram data is input to
a reconstruction method, yielding a reconstructed image f̂ consisting of M voxels. Denote
the process of obtaining the reconstructed image from the original tracer distribution by the
operator Θ : L2 (R3 ) → EM . Our objective is to segment the reconstructed image into K
regions, in this case, the left and right caudate, putamen, and GP regions, with the rest of
the region labeled as the background. Typically this is performed by labeling each voxel
in the reconstructed image to one region. However, as mentioned above, this segmentation
is unable to account for tissue-fraction effects. Thus, we instead frame the segmentation
problem as estimating the fractional volume occupied by the k th region in each voxel of the
reconstructed image f̂ .
Let the support of the k th region be given by φk (r). Mathematically,

φk (r) =


1,

if region k occupies location r.

(2.1)

0, otherwise.
Also, let the distribution of tracer uptake within the support of each region be given by
fk (r). Then f (r) can be described as follows:
f (r) =

K
X

fk (r)φk (r).

k=1
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(2.2)

Next, define the voxel function ψm (r) as

1, if r lies within the mth voxel.
ψm (r) =
0, otherwise.

(2.3)

Let V denote the total volume of each voxel. The fractional volume occupied by the k th
region in the mth voxel, denoted by videal,k,m , is given by
videal,k,m

1
=
V

Z

φk (r)ψm (r)d3 r.

(2.4)

Estimating the fractional volumes within each voxel thus requires estimating the values of
φk (r) from f̂ . This is an ill-posed problem due to the null functions of the Θ operator. One
way to alleviate the ill-posedness is to incorporate prior distribution about φk (r). However,
this requires access to the distribution of f (r), or at least φk (r), at infinitely high resolution.
Liu et al. [58] proposed a simulation-based strategy for this purpose, where in the context
of oncological PET, they simulated tumors at very high resolution. However, their strategy
required simulating tumors and then validating their realism.
In our problem, we benefit from the availability of existing MR image populations, which can
be used to provide the distribution of φk (r) at relatively higher resolution. More specifically,
the anatomical structures of the caudate, putamen and GP regions are distinguishable on
MR images due to the higher resolution of MRI. The MR images can thus be segmented to
yield the support of these regions. Thus, from previously acquired MR images, a distribution
of the support of these regions can be obtained.
Denote the MR image by an N -dimensional vector fM R , where N > M . The voxel function
MR
for this image is denoted as ψm
(r). Assume that this image has been segmented into K
R
distinct regions. For each region, we define a N -dimensional vector φM
k , which denotes the
mask for that region. The elements of this vector are defined as follows:
R
φM
k,i


1, if voxel i in the MR images is assigned to region k.
=
0, otherwise.
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(2.5)

A high-resolution estimate of the fractional volume occupied by the k th region in the mth
voxel of the SPECT image, denoted by vk,m , is then given by
vk,m

Z
M
1 X MR
MR
φk,m0 d3 r ψm
=
0 (r)ψm (r).
V m0 =1

(2.6)

We frame our problem as the task of estimating {vk,m , k = 1, 2, . . . K, m = 1, 2, . . . M } from
the reconstructed SPECT images.

Estimation technique
Denote the estimate of vk,m by v̂k,m . Denote the vector {vk,m , m = 1, 2, . . . M } by vk , and
the estimate of vk by v̂k . To compute v̂k from the reconstructed SPECT image f̂ , we first
need to define a cost function. The values of vk,m and v̂k,m lie between 0 and 1. Thus, if we
treat these values as probabilities, the binary cross entropy (BCE) between vk,m and v̂k,m
automatically incorporates this constraint on the range of these values [11]. Therefore, the
BCE loss, denoted by lBCE (vk,m , v̂k,m ), and given by the equation below is chosen as the basis
of the cost function:
lBCE (vk,m , v̂k,m ) = vk,m log(v̂k,m ) + (1 − vk,m ) log(1 − v̂k,m ).

(2.7)

The cost function, denoted by C(vk , v̂k ), minimizes the negative of the BCE loss between
vk,m and v̂k,m over all M voxels, averaged over the ensemble of true values vk,m and the noise
in the imaging process. The cost function is then given by:
C(vk , v̂k ) = −

M Z Z
X

p(f̂ , vk,m )lBCE (vk,m , v̂k,m )dvk,m dM fˆ.

m=1
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(2.8)

We use Bayes theorem to expand p(f̂ , vk,m ) and replace the expression from Eq. (2.7) in the
cost function (Eq. (2.8). This yields:
C(vk , v̂k ) = −

M Z
X

Z
p(f̂ )

p(vk,m |f̂ ) [vk,m log(v̂k,m ) + (1 − vk,m ) log(1 − v̂k,m )] dvk,m dM fˆ

m=1

=−

=

M
X

m=1
M
XZ

Z

Z
p(f̂ )

p(vk,m |f̂ ) [vk,m {log(v̂k,m ) − log(1 − v̂k,m )} + log(1 − v̂k,m )] dvk,m dM fˆ



Z

p(f̂ ) {log(v̂k,m ) − log(1 − v̂k,m )}


p(vk,m |f̂ )vk,m dvk,m + log(1 − v̂k,m ) dM fˆ.

m=1

(2.9)
The term p(f̂ ) is always positive. Thus, the cost function is minimized by setting


Z
∂
{log(v̂k,m ) − log(1 − v̂k,m )} p(vk,m |f̂ )vk,m dvk,m + log(1 − v̂k,m ) = 0.
∂v̂k , m

(2.10)

The solution is given by
∗
v̂k,m

Z
=

p(vk,m |f̂ )vk,m dvk,m .

(2.11)

This is simply the posterior mean estimate of vk,m . Thus, by developing an optimization
routine that minimizes the loss function in Eq. (2.7), we can estimate the fractional volume
that a region occupies in each voxel. From this estimate, the segmented boundaries of the
different regions can be obtained, as we define later. We first describe the procedure to
develop such an optimizer.

2.2.2

Implementation

An encoder-decoder-based architecture was implemented to minimize the cost function defined in Eq. (2.7). The auto-encoder was input the 3D SPECT images and corresponding
ground-truth masks for training. On being trained, the network, when input a 3D SPECT
image, estimates the fractional volumes of the of left and right caudate, putamen and GP,
which are then used to define the 3D delineations of these regions. The network architecture
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is shown in Fig. 2.1. The architecture is similar to a modified U-net as proposed in Leung
et al. [54], but with some differences. The major difference is that the argmax layer is not
present. This allows the network to output a continuous valued estimate of the fractional
volume within each voxel, as a number between 0 and 1. This network design is similar to
other networks that are designed for estimation-based tasks, such as those for denoising [11]
and reconstruction [69]. The detailed architecture is shown in Appendix A. We implemented
this approach in 3D instead of conducting slice-by-slice segmentation or patch-based training
[41] to provide the maximal amount of global contextual information per patient image.

Figure 2.1: The auto-encoder architecture for performing the segmentation of the DaTScan
SPECT images. The network is input a 3D SPECT image, and outputs the estimated
fractional volumes of the different regions.
The method was implemented on systems with NVIDIA Titan RTX GPU and NVIDIA V100
graphics processing unit (GPU) cards, allowing effective training with 3D images. Tensorflow
1.10.0 was used with Keras. Also, Python 3.7 programming language was used.

2.2.3

Evaluation of the proposed method

Evaluation of the proposed method requires access to DaT-scan SPECT images where the
ground-truth boundaries of the various regions are known. One approach to conduct such a
study is to have ground-truth boundaries defined by expert readers. However, this approach
is likely erroneous with SPECT as the manual delineations are not guaranteed to be accurate
due to the PVEs in SPECT. In fact, the GP is manually almost impossible to delineate on
the SPECT scan. Further, the boundary between the caudate and putamen is unclear. All
these factors make obtaining manual delineations nonviable. Another evaluation approach is
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a setup where both the MR and DaT-scan SPECT images for a certain set of patients were
acquired. However, such images are difficult to obtain due to the lack of joint SPECT/MR
systems. In some cases, SPECT and MR images from different scanners may be available.
However, using these images requires assuming that the MR and SPECT scans are perfectly
aligned, which is not guaranteed. Further, this approach assumes similarity of the functional
boundary on the SPECT and the anatomical boundary on the MR image.
To address these issues, we perform this evaluation in a more controlled setting through
realistic clinically guided simulation studies where the above-mentioned assumptions do not
need to be made. In these studies, clinical MR images are used to generate clinically realistic
SPECT images by modeling the physics of SPECT. This process inherently ensures that the
MR-defined ground-truth boundaries of the various regions in the generated SPECT images
are known and that the images are aligned perfectly. Further, this approach allows us to
precisely and quantitatively study the effects of misalignment between the SPECT and MR
images, and the mismatch between the MR functional and SPECT anatomical boundaries.
Note that while this strategy requires simulation of SPECT system, the true distribution of
the fractional volumes of the different regions is not simulated and is obtained directly from
clinical studies. In this section, we describe the process followed to rigorously evaluate the
proposed method using this simulation-based approach.

Generating realistic SPECT images
A total of 600 T1-weighted MR images from the Open Access Series of Imaging Studies
(OASIS)-3 [48] and Alzheimer’s Disease Neuroimaging Initiative (ADNI) [74] databases were
used. These images were segmented into grey matter, white matter, caudate, putamen
and GP for both left and right hemispheres using the Freesurfer software. The delineation
was performed in Montreal Neurological Institute (MNI) space into 256 × 256 × 256 voxels
with voxel size of 1 mm. The resulting delineations of MR images yielded 600 anatomical
templates of the brain. Next, an in vivo distribution of DaT activity ratios in the different
regions of the brain, as obtained from clinical data in Lee et al. [53], was defined. For each
anatomical template, this distribution was sampled to determine the DaT activity ratios in
the various regions. This process ensured clinically realistic variability of activity uptake
for the different subjects. At the end of this process, we had a digital phantom population
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of 600 patients with anatomical templates directly obtained from clinical data and tracer
distributions guided by clinical data.
This ground-truth tracer distribution was used to generate realistic DaT-scan SPECT images. A SPECT system modeling a DaT-scan study with 123-Ioflupane tracer and a lowenergy high-resolution (LEHR) collimator was simulated. System parameters were similar
to a GE Discovery 670 (GE Healthcare, Haifa, Israel). The simulation process modeled the
various aspects of SPECT imaging, including the finite extent of the collimator, the finite
energy and spatial resolution of the detectors and the photon attenuation. The number of
total counts was scaled down to clinically realistic value of 2 million counts [15], to which
Poisson noise was added. The noisy projection data were reconstructed using an iterative
3D order-subsets expectation-maximization (OS-EM) algorithm with 4 iterations and 8 subsets, as in typical SPECT reconstruction protocols. The OSEM technique compensated for
attenuation and collimator-detector response. The reconstructed images were of dimensions
128 × 128 × 128. The images were reconstructed at two voxel sizes, namely 2 mm and 4 mm.
This was done to study the performance of the segmentation method for these two clinically
relevant voxel sizes and evaluate the sensitivity of our method to voxel size. The overall
process to generate the SPECT images is summarized in Fig. 2.2.

Figure 2.2: Workflow to simulate the SPECT images. DaT activity distribution map in
relevant regions was attained from clinical data and structural boundaries from MR images.
The digital phantom was then used for highly realistic SPECT simulation and 3D OS-EM
reconstruction to generate reconstructed images.

23

Training and evaluation strategy
The 600 reconstructed 3D SPECT images were divided into two independent sets of 500
training images and 100 testing images. The training images were used to train the proposed
method, while the testing images were used for qualitatively and quantitatively evaluating
the performance of the method. The performance of the method was compared with several
commonly used methods that have been used for SPECT segmentation. These included a
Markov random fields-Gaussian mixture model (MRF-GMM)-based method [33, 38, 91], an
active-contour-based technique, namely Snakes, [43], a thresholding-based technique, namely
40% SUV-max thresholding [46] and finally a state-of-the-art U-net-based technique [54] For
the first three segmentation methods, the 40% SUV-max, Snakes and MRF-GMM, a manual
input, which could be a seed voxel or an initial boundary estimate, was provided to the
segmentation technique. The proposed method and the U-net-based method did not require
any user inputs, and were fully automated.
Quantitative evaluation on the segmentation tasks was performed using metrics that evaluated spatial overlap and shape similarity. Note that the output from the segmentation
method is an estimate of the fractional volume, which is a number between 0 and 1. Conventional segmentation methods typically assign a voxel to only a single class. For these
methods, the spatial overlap is quantified using Dice similarity coefficient (DSC) and Jaccard similarity coefficient (JSC). Since our method yields a number between 0 and 1, we
used the fuzzy analog of these metrics, namely the fuzzy DSC (fDSC) and fuzzy JSC (fJSC),
as defined in Taha et al [95]. Higher values of these metrics indicate a more accurate segmentation. Also, the similarity in shapes between the true and estimated segmentations was
quantified using the Hausdorff distance (HD) [31]. HD measures the maximum deviation between the predicted and true segmentation boundaries. Thus, lower value of HD represents
higher shape similarity.

Studying effect of mismatch between MR and SPECT images
The proposed approach is trained in a setting where the alignment of the SPECT image
with the corresponding MR images and the similarity of the MR anatomical and SPECT
functional boundaries are enforced by default. However, a new SPECT image to which
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this trained network is applied may not necessarily satisfy these conditions. For example,
the new SPECT image may be misaligned compared to the MR images in the training set.
Similarly, there may be a mismatch between the SPECT functional and the MR anatomical
boundaries. To evaluate the sensitivity of our method to these sources of mismatch, we
conducted the experiments as described in the next two sub sections.
Misalignment between MR and SPECT images: Our network was trained using a
clinical MR population that was registered on the MNI space. In a realistic scenario, it may
be possible that the SPECT scan of a new patient may be misaligned with this space. To
simulate this effect, we evaluated the performance of our method when input SPECT test
images were misaligned compared to the MR image population. A total of 100 test images
were misaligned by rotating them in steps of 2 degrees, for up to a maximal rotation of ±10◦ .
The misalignment was introduced in the x-y plane. The sensitivity of the network to this
misalignment was quantified using the fDSC metric.
Mismatch between functional SPECT and anatomical MR boundaries: The MR
images provide the anatomical boundaries of the caudate, putamen, and GP regions. In
contrast, the SPECT images provide the functional boundaries of these regions. In SPECT
images of patients with higher severity of PD, the functional boundary of the putamen is
typically smaller on the lower side of putamen in an axial view often asymmetrically [72].
As patients with PD progress, it has been observed that the affected putamen changes from
a bean shape to a smaller size and circular shape in the SPECT image. In other words,
it appears that the functional boundary of putamen is smaller. Further, uptake in the GP
is typically non-existent in patients with more severe PD [52]. Thus, in summary, there is
a potential of mismatch between the functional boundaries as defined on the SPECT and
the anatomical boundaries as defined on the MR images. This is as shown in example in
Fig. 2.5. We investigated the sensitivity of our method to this mismatch. For this purpose,
in the test set, we simulated SPECT images with no uptake in the GP and progressively
reduced functional size of the putamen, corresponding to different levels of disease severity.
All 100 test subjects were used in this study. In each test subject, the functional boundary
of the putamen was reduced compared to the anatomical boundary in steps of 10%, to up to
90%. In this study, only functional boundaries are affected and anatomical boundaries are
not changed
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2.3
2.3.1

Results
Qualitative evaluation

We first present representative qualitative results that provide context to the quantitative
findings discussed in the next section. The segmentation boundaries estimated using the
different methods for 2 mm voxel size SPECT images are shown in Fig. 3.1. The proposed
method closely matched the ground-truth boundary. This is shown more clearly using the
zoomed results in Fig. 2.4. These figures also illustrate the challenging nature of the segmentation task, as due to PVEs, the boundary between the different regions is highly blurred.
As a result of this, the 40% SUV-max and active-contours method were not even able to segment the various regions separately. The MRF-GMM technique could segment three regions
but the overlap between the predicted and the ground truth was not that high. In contrast,
the proposed method yielded accurate segmentation of all the individual regions.
In Fig. 2.5, a visual comparison of performance of proposed segmentation method is provided
for a healthy and a diseased patient. In the healthy patient, the anatomical and functional
boundaries match. In the diseased patient, the functional boundary of the putamen is
reduced and there is no uptake in the GP. The proposed segmentation method yielded a
similar delineation as the true functional boundary in both these cases. Also, note that the
proposed segmentation method did not yield a functional boundary for the GP region, thus
correctly reflecting the zero-valued uptake in the GP and further demonstrating the accuracy
of the proposed method.

2.3.2

Quantitative evaluation

In our qualitative results, we observed that the 40% SUV-max and Snakes methods were
unable to separately segment caudate, putamen and GP regions. Thus, in the quantitative
evaluations, the resultant total regions of striatal and pallidal region were used for 40%
SUV-max and Snakes methods. In other words, since these methods provided a single
combined segmentation of these regions, the combined regions were used for the quantitative
studies. The top row in Fig. 2.6 shows that for the voxel size of 2 mm, the proposed method
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Figure 2.3: Visual comparison of the segmentation methods
outperformed other segmentation methods on the basis of the fDSC, fJSC, and HD metrics
(p value <0.01). Also, the proposed method yielded a fDSC close to 0.8 for all the regions,
thus indicating an accurate segmentation [105]. The existing semi-automated methods were
highly inaccurate for the caudate and GP regions. While the proposed and the U-netbased methods were more accurate for these regions, the proposed method significantly
outperformed the U-net-based method (p value <0.01).
Similar results were seen for the reconstructed images with voxel size of 4 mm on each
side, as shown in the bottom row of Fig. 2.6. Further, the values of fDSC, fJSC and HD
remained relatively unchanged in going from 2 mm voxel size to 4 mm voxel size for the
proposed method. This indicates the relative insensitivity of the method to change in voxel
sizes. In contrast, the performance of the U-net-based method, which does not model TFEs,
significantly deteriorated for the higher voxel size. This was because the proposed method
accounts for the TFEs unlike the U-net-based method.
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Figure 2.4: 3D segmentation of the proposed method and comparison with the ground truth.
The upper slice shows an axially upper slice and lower slice shows axially lower slice of the
current slice.
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Figure 2.5: 3D segmentation of the proposed method for visual comparison of normal activity
and affected DaT levels where a asymmetrically reduced activity in the putamen is simulated.

Figure 2.6: Comparison of the fDSC, fJSC, and HD from left to right respectively obtained
using the five segmentation methods that allows separate segmentation for images with 2 mm
voxel size (top row) and 4 mm voxel size (bottom row).
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The accuracy of the proposed method when the MR and SPECT images were misaligned is
shown in Fig. 3.2. The proposed method continued to yield accurate segmentation between
−4 and 4 degree of misalignment. Also, for larger misalignment, while the performance of
the proposed method was slightly affected, the fDSC values were still close to 0.8 for both
2 mm and 4 mm voxel sizes, indicating a good segmentation accuracy.

Figure 2.7: The accuracy when MR and SPECT images are mis-registered. The left figure
shows results with 2 mm voxel size and right figure shows results with 4 mm voxel size.
The sensitivity of the method to mismatch between the functional boundary and the MRdefined anatomical boundary is shown in Fig. 2.8. As the available functional boundary
decreased, the fDSC scores reduced. However, the proposed method yielded more than 0.7
DSC value for up to the case where the functional boundary of the putamen was 40% of the
anatomical boundary.

2.4

Discussions

Overall, the results demonstrate the efficacy of the proposed method in reliably segmenting the caudate, putamen, and GP regions from DaT-scan SPECT images. The ability of
segmenting the small-sized GP region in particular, is distinctive as the GP is visually almost impossible to demarcate on the SPECT images. It is well known that the GP plays
an important role in the movement-related direct and indirect pathways of basal ganglia
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Figure 2.8: The figure shows results with 2 mm voxel size on the left and 4 mm voxel size
on the right with asymmetrically reduced functional uptake in the left and right putamen.
[49]. There has been interest in studying the plasticity of the nigro-pallidal pathway [100].
Quantification of the DaT uptake in the pallidal regions may provide new insights on this
plasticity. Several post-mortem studies have shown evidence of DaT uptake in the pallidal
regions [8, 75] DaT-scan SPECT studies provide a mechanism to study these effects in vivo
but this has been hindered by the lack of tools to segment the pallidal regions on the SPECT
images. Our results show that the proposed method can help to address this challenge. Thus,
this result opens up a new and important research frontier on analysing the functional characteristics of the GP region in patients with Parkinson’s disease. Additionally, the method
also provides an accurate delineation of the caudate and putamen regions in the SPECT
images. This provides tools to conduct shape analysis of these regions, which may lead to
new biomarkers for diagnosis and measuring severity of Parkinson’s disease.
We observe from Fig. 2.6 that the proposed method outperforms several existing segmentation methods, including a U-net-based approach [54]. The U-net based approach also learns
anatomical variability and PVEs arising due to limited system resolution, but does not account for the TFEs, unlike the proposed method. An increase in the voxel size in SPECT
increases the TFEs. Thus, the proposed method performs better than other segmentation
methods especially when the voxel size is larger. This explains the larger difference in the
DSC and JSC values between the proposed and the U-net-based method when the reconstructed images have 4 mm voxel size. The higher accuracy of the proposed method at 4 mm
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voxel size is especially significant as many clinical DaT SPECT scans are recommended and
conducted with 4 mm voxel sizes [15]. Next, we also observe in Fig. 2.6 that an increase in
the voxel size from 2 mm to 4 mm did not affect the DSC of the proposed method, but the
DSC of the U-net-based approach decreased by more than 10%. This provides evidence that
the proposed approach is relatively robust to changes in voxel size. This again demonstrates
that accounting for TFEs provides distinct and clinically relevant advantages to this method
compared to existing methods.
Another class of methods to segment the striatal regions in DaTscan SPECT images have
been those that use the MR images acquired from a different scanner [77]. These methods
have not been evaluated on the task of segmenting GP. Further, these methods require that
both SPECT and MR images of the same patient be available, which is typically not the
case, and even when available, is likely from a different time point. While there has been
some recent progress in the area of developing simultaneous SPECT/MR systems [32], no
clinical simultaneous SPECT/MRI systems are currently available. In contrast, the proposed
method does not require the corresponding MR image from the patient to perform the
segmentation and works on stand-alone SPECT images.
We also observe that the proposed method is accurate even when there is some degree of
mismatch between the SPECT and MR images. While this observation may seem confounding at first, note that the proposed method estimates the posterior mean of the fractional
volumes that a region occupies within a voxel. This posterior mean depends on the input
test SPECT image that is being segmented. Thus, the performance of the method is not necessarily effected when the mismatch between the training and test set is small. Developing a
theoretical formalism that can quantify the tolerability of this mismatch is an important research frontier. Nevertheless, our results in Fig. 3.2 show that for up to 10% of misalignment
between SPECT and MR images, the performance of the method is relatively robust. This
is encouraging as the main challenge occurs when the degree of misalignment is small, since
that is visually difficult to identify. In contrast, higher degrees of misalignment are visually
easier to identify, and thus, in those cases, the SPECT images can be first registered to the
MR MNI space. After registration, there may still be small degrees of misalignment, but
our results show that this would not affect the performance of the method. Similarly, our
results in Fig. 2.8 show that the method yields accurate segmentation even when the functional boundary is only 40 % of the anatomical boundary. Clinically, functional boundaries
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lower than these are typically not observed [71]. Thus, this result provides evidence that the
proposed method is relatively robust to mismatches between the functional and anatomical
boundaries for clinically relevant purposes.
Our study has some limitations. The first limitation is that the method was evaluated using
simulation studies. While the simulations used clinical MR images as anatomical templates,
were clinically guided and highly realistic, they may have not been able to account for all
sources of population variability and account for all aspects of the imaging physics. Evaluation using physical-phantom and patient-data-based studies can help address this limitation.
Evaluation using physical phantoms will model all aspects of the system instrumentation.
Similarly, evaluation with clinical datasets will account for any missed sources of population
variability. This is an important area of future study. Another limitation is that in this
manuscript, we focused on the task of segmenting the caudate, putamen and GP regions in
the DaT-scan images and considered the rest of the region as background. However, postmortem studies indicate DaT uptake in other regions in the basal ganglia such as the nucleus
accumbens and substantia nigra [93]. Also, the GP can itself be separate into two parts,
namely the internal and the external GP. Results from this study motivate extending the
proposed approach to consider these segmentation tasks. Finally, in our simulation studies,
we assume that the uptake within the various regions is uniform. However, the tracer uptake
within the putamen may be heterogeneous in patients with PD. Modeling this heterogeneity
and evaluating the performance of the proposed segmentation method in the presence of this
heterogeneity are important research areas.

2.5

Conclusions

An estimation-based fully automated method to segment the caudate, putamen, and globus
pallidus regions from 3D DaT-scan SPECT images has been proposed. The method accounts
for both sources of partial-volume effects in SPECT images, namely system-generated blur
and tissue-fraction effects. Essentially, the method estimates the posterior mean of the
fractional volume that the different regions occupy in each voxel, a distribution of which
can be obtained from existing MR image populations. Rigorous evaluation using realistic
simulation studies conducted with clinically derived data demonstrated that the method
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provided accurate delineation of the caudate, putamen and GP for 3D DaTscan SPECT
images. The method outperformed existing methods including a U-net-based approach, and
was relatively insensitive to the choice of two different voxel sizes. Further, the method
was robust to misalignments between the SPECT test image and MR image populations,
and mismatches between the MR anatomical boundary and the functional boundary in
the SPECT test image. Overall, the results provide strong evidence of the efficacy of the
segmentation method and motivate further evaluation with physical phantoms and patient
data.
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Chapter 3
Compensating for partial volume
effects in DaTscan SPECT

3.1

Introduction

A major challenge to quantitative DaTscan imaging is the partial volume effects that are
present in DaTscan SPECT images. Due to limited collimator-detector response of the
system, structures smaller than 3 times of FWHM are more prone to PVEs [103, 17]. The
issue is compounded when these small regions are adjacent to each other, as is the case with
DaTscan SPECT where the caudate, putamen, and globus pallidus (GP) are often lying
next to each other [103, 17]. Also, tissue fraction effects (TFEs) due to generally larger
voxel sizes in SPECT add to the PVEs. These limitations often lead to large bias in brain
SPECT when performing quantitative studies [103, 18, 17]. In previous SPECT simulations
and quantification of regions, there has been a reported underestimation of uptake within
region of interest that was especially significant as the size of structures decreased [103].
This occurred because of PVEs related to the spatial resolution of the imaging system [103].
To compensate for these effects, a partial volume compensation method has been previously
introduced by Rousset et al [81]. The method used a geometric transfer matrix (GTM) to
calculate the spill over effects of an ROI and surrounding regions and incorporated these
effects for correction of mean uptake value [81]. In previous studies, application of this
method led to significantly lower biases. [18, 17]. In these studies, acquiring a ground-truth
mask for the region of interest (ROI) was needed. However, in clinical settings, ground-truth
ROIs and accurate segmentation of ROIs may not be available. The segmentation method
35

proposed in Chapter 2 provides a mechanism to address this issue. We now propose a novel
PVC technique that builds upon the segmentation technique proposed in Chapter 2.

Figure 3.1: (A) Original true activity distribution. (B) The spilling out effect. (C) Spilling
in effect due to spilling out from (B). (D) Resulted measured image. Original figure from
Soret et al. [87]

3.2
3.2.1

Methods
Theory for Continuous GTM Method

Let f (r) denote the true tracer activity distribution over K number of distinct tissue components each with a ROI denoted by χi (r).
f (r) =

K
X

λi χi (r).

(3.1)

i=1

Consider imaging this tracer distribution through a SPECT system with field of view of
Sf . The SPECT imaging process can be described as a linear operator. Also SPECT
reconstruction methods that sufficiently compensate for image-degrading processes can be
described as approximately linear [34]. Here we assume that the SPECT system and the
reconstruction operator can be together described as a linear operator. Let hm (r) denote
the M-dimensional kernel of this linear operator. Let θ̂m is the reconstructed SPECT image
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resulted from tracer distribution f (r).
Z

d3 rhm (r)f (r).

θ̂m =

(3.2)

Sf

Let r0 denote the 3D spatial coordinate in the reconstructed image space. The reconstructed
image fˆ(r0 ) is represented in discrete space with the voxel expansion function given by φm (r0 )
and combined with Eq. 3.2 to represent reconstructed image continuous space.
fˆ(r0 ) =

M
X

θ̂m φm (r0 )

(3.3)

m=1

Z

d3 r

=
Sf

Z

M
X

hm (r)φm (r0 )f (r)

(3.4)

m=1

d3 rk(r0 , r)f (r).

=

(3.5)

Sf

where,
k(r0 , r) =

M
X

hm (r)φm (r0 ).

(3.6)

d3 rk(r0 , r)χi (r).

(3.7)

m=1

Substituting Eq. 3.1 into Eq. 3.5, yields
fˆ(r0 ) =

K
X
i=1

Z
λi
Sf

0

Denote the volume and mean estimated activity uptake in the j th ROI by Vj and λj . Then,

λ0j

1
=
Vj

Z

d3 r0 fˆ(r0 )χj (r)

(3.8)

Sf

Z
Z
N
1 X
3 0
0
=
λi
d r χj (r )
d3 rk(r0 , r)χi (r).
Vj n=1
Sf
Sf
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(3.9)

where in the second step, we substitute the expression from Eq. 3.7. For simplicity of
notation, we define the weight coefficients wji .
λ0j

=

N
X

λi wji .

(3.10)

n=1

where from Eq. 3.9, wji is defined
1
wji =
Vj

Z

1
=
Vj

Z

3 0

0

Z

d3 rk(r0 , r)χi (r)

d r χj (r )
Sf

(3.11)

Sf
3 0

0

Z

3

d r χj (r )
Sf

dr
Sf

M
X

hm (r)φm (r0 )χi (r).

(3.12)

m=1

For simplicity, we define wji in operator notation. Denote the SPECT projection and reconstruction operators by P and R. Let D† represents the adjoint of the discretization operator.
This adjoint operator is given by

†

[D θ̂] =

M
X

θ̂m φm (r).

(3.13)

m=1

Then, wji is given by
wji =

1
ROIj · D† {R{P{ROIi }}}.
Vj

(3.14)

With this definition for the weight coefficient, using Eq. 3.10, the activity uptake in the j th
ROI from the reconstructed image can be written in matrix form as follows:
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ω11
λ01
 0 
 λ2   ω12
 . = .
 .   .
 .   .
λ0N

ω21
ω22
..
.

ω1N ω2N

 
· · · ωN 1
λ1
 
· · · ωN 2   λ2 
 
.. 
..
  .. 
.
.  . 
· · · ωN N
λN

Denote the vectors [λ1 . . . λN ] and [λ01 . . . λ0N ] by Λ and Λ0 , respectively. Also, denote the
matrix consisting of the weights by W . Then, the above equation can be written in vector
notation as follows:
(3.15)
Λ0 = W λ.
Therefore, to estimate λ, we can simply taken the inverse of the W matrix. In other words
Λ = W −1 Λ0 .

3.2.2

(3.16)

Evaluation of the Proposed Method

To quantitative evaluate the proposed PVC method, we first used the segmentation method
proposed in Chapter 2 to calculate the average mean uptake of caudate, putamen and globus
pallidus regions from the reconstructed images for both hemispheres. However, the proposed
segmentation did not include segmentation of the background region of the brain. Thus, the
segmentation of the background wass estimated by subtracting regions of caudate, putamen
and globus pallidus from a normalized reconstructed image. This allowed a fair estimation
of the background with only using already available reconstructed images and segmentations
from the proposed method.
The segmented masks of regions are projected and reconstructed using the same simulation
and reconstruction protocol that are used for DaTScan images. Then by using the reconstructed images of the segmented regions and continuous GTM method, corrected mean
uptakes of the regions are calculated for both 2 mm and 4 mm voxel sizes. The experiment
was performed for the 100 test subjects described in Chapter 2.
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3.3

Results

As shown in Table 3.1, the percent bias of caudate improved from ∼ 47% to ∼ 34 %, that of
putamen improved from ∼ 27 % to ∼ 15 % for 2 mm voxel size. The percent bias of globus
pallidus and background also improved, but the improvement wasn’t significant. Also, the
PVC results for voxel size of 4 mm is shown in Table 3.2. The percent bias of caudate
improved significantly from ∼ 44% to ∼ 11 %, that of putamen improved from ∼ 23 % to ∼
12 %. Similarly to results of 2 mm voxel size, the correction didn’t have significant effect on
the percent bias of globus pallidus and the background. Generally, the uncorrected percent
bias for 2 mm voxel size was marginally larger than that of 4 mm voxel size DaTScan images.

Left Caudate
Left Putamen
Left Globus Pallidus
Right Caudate
Right Putamen
Right Globus Pallidus
Background

Uncorrected Bias (%) Corrected Bias (%)
46.7419
31.7106
45.4816 48.0022
30.2190 33.2022
26.1385
13.9927
24.6306 27.6465
12.0097 15.9756
23.6298
22.5707
20.6010 26.6587
19.4549 25.6866
48.0064
36.664
46.6916 49.3212
35.2706 38.0573
28.0093
16.503
26.5426 29.4761
14.6159 18.3900
23.7889
22.6295
20.7527 26.8251
19.4832 25.7757
43.0431
40.3054
37.4962 48.5900
34.4820 46.1289

Table 3.1: The uncorrected bias and corrected bias in percentage of mean uptake values
for both left and right caudate, putamen, globus pallidus and the background for DaTScan
images with 2 mm voxel size are shown

3.4

Discussions and Conclusion

The improved segmentation results from Chapter 2 has a lot of potential for direct analysis
of the segmented regions of the caudate, putamen and globus pallidus.
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Left Caudate
Left Putamen
Left Globus Pallidus
Right Caudate
Right Putamen
Right Globus Pallidus
Background

Uncorrected Bias (%) Corrected Bias (%)
43.6016
10.5099
42.6330 44.5702
9.2155 11.8043
22.2876
12.824
20.7849 23.7902
11.2412 14.4067
22.7521
21.8267
20.3022 25.2019
19.0842 24.5692
44.2827
12.4345
43.2589 45.3065
11.0338 13.8353
23.843
12.0203
22.3781 25.3079
10.4671 13.5735
23.6498
24.2659
21.0415 26.2580
21.4030 27.1288
51.7421
50.898
47.0170 56.4673
46.0639 55.7322

Table 3.2: The uncorrected bias and corrected bias in percentage of mean uptake values
for both left and right caudate, putamen, globus pallidus and the background for DaTScan
images with 4 mm voxel size are shown

Figure 3.2: Plot for the percent bias comparison between corrected and uncorrected results
for 2 mm voxel size on the left and 4 mm voxel size on the right
The quantification results of caudate and putamen improved significantly with PVC method
using GTM based on proposed segmentation as shown in Table 3.1 and Table 3.2. The
PVC results for 4 mm voxel size improved more significantly than those of 2 mm voxel size
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similarly with the segmentation results in Chapter 2. This improvement is clinically relevant
as most clinical DaTScan protocols are conducted to create ∼ 4 mm pixel size images [15].
However, the results with globus pallidus and the background didn’t improve as significantly.
This motivates the need for even more improved PVC methods. An interesting direction is
extending a perturbation-based GTM (pGTM) approach as proposed in Du et al. [17] . The
pGTM approach has been observed to yield improved performance on PVC by attempting to
account for the non-linearity of the reconstruction operator. Extending this approach for a
continuous estimate of the region boundary can further improve quantification performance
and is an important research frontier.
In summary, the proposed PVC method integrated with the segmentation method shows
significant potential for improving estimates of uptake within regions of interest from the
DaTscan SPECT images, that it does not need the ground truth boundaries of the region
of interest as needed in previous studies [17, 87, 81]. Also, the method is fully automated as
it does not require any manual segmentation of the different regions in the SPECT image.
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Chapter 4
Conclusions and Future work

4.1

Overview

This study has been conducted in order to address in an important need for developing
biomarkers to improve diagnosis and measure the severity of PD. The key goal was to
achieve reliable quantification of uptake from the DaTscan SPECT images. Reliable quantification from reconstructed images requires an accurate segmentation of these regions. This
was a challenge for DaTScans due to the limited spatial resolution, partial volume effects,
high noise, physiological variability and small size of the regions of interest. To address
these issues, we developed a 3D physics-guided estimation-based method by integrating the
prior distribution acquired from MR images for DaTScan SPECT image segmentation. A
Bayesian approach that estimates the posterior-mean of the fraction volume that a particular regions of interest occupy within each voxel of a SPECT image was developed. The
method was implemented using an auto-encoder that was optimized and trained with 500
images and tested on 100 images. The method yielded quantitatively and qualitatively improved segmentation results outperformed previously developed methods, and was relatively
insensitive to different types of mismatch between the training and testing. Following this,
a geometric transfer matrix (GTM)-based approach was extended to perform partial volume
compensation (PVC) from the DaTscan SPECT images. A GTM method for partial volume
compensation used the segmented masks estimated from the proposed segmentation method
and provided significantly improved estimate of average uptake in the striatum region.
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4.2

Evaluation with Physical-Phantom Study

As mentioned in Chapter 2, an important research frontier is validating the segmentation
method using physical-phantom studies. For this purpose, we have collaborated with 3D
printing lab at Mallinckrodt Institute of Radiology for designing and printing 3D physical
brain phantom that has separate tracer fillable regions for caudate, putamen, globus pallidus
and the background as shown in Fig 4.1 [64]. The physical phantom experiment, where we
would fill different regions with different Ioflupane uptake values and scan with a SPECT system available at Washington University School of Medicine, could help validate the proposed
method.

Figure 4.1: Printed brain phantom

4.3

Evaluation with Patient Studies

It is important to perform a patient study for final validation of the proposed method if
clinical data is available. This would require obtaining at large number of clinical DaTScan
images. There is an open database from Parkinson’s progression marker initiative (PPMI)
where hundreds of DaTScan images are available. This database provides a resource to
evaluate the proposed methods.
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Figure 4.2: Axial DaTScan image from PPMI. Image adopted from PPMI website [64]

4.4

Performing Quantification with List-mode Data

Another challenge in evaluation with patient data is the lack of ground-truth quantitative
values. This lack of ground-truth data is generally an issue in evaluating quantitative imaging
methods. To address this issue, no-gold-standard (NGS) evaluation techniques have been
developed [36, 39, 34, 37, 35, 47, 27]. In this thesis, we explored the use of existing NGS
evaluation procedures for evaluating the DaTscan SPECT image analysis methods. However,
the performance of these methods was limited. More recently, a novel NGS evaluation
procedure has been developed [56] that addresses some of the limitations of the existing
NGS evaluation techniques. Developing and evaluating this NGS evaluation procedure for
quantitatively evaluating the proposed segmentation method with patient data is another
important research direction.

4.5

Shape and Texture Analysis

As shown in Chapter 2, significantly improved segmentation accuracy of caudate, putamen
and globus pallidus has potential for several practical implications. First, because previous
shape and texture analysis methods of DaTScan images were conducted using simple and less
reliable segmentation methods such as thresholding, the improved segmentation accuracy of
the proposed method could help and improve predicted outcome of these studies [89, 76].
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Also, separate segmentation of caudate, putamen and globus pallidus could lead to separate
shape analysis of different regions of the brain which could be more advantageous that
evaluating the striatum as a whole. Further, significantly improved percent bias of mean
uptake for caudate and putamen have potential for future usage and further validation.
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